Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators

Drug linked to a 45% lower risk of dying among COVID-19 patients on ventilators

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn’t receive the drug, according to a new study by a team from the University of Michigan.
Read more “Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators”

Address

5.5km, Near Ali Raza Abad, Holiday Park, Plot No.27, Raiwind Road, Lahore,Pakistan

+92 42 35230774/5

contact@rascopharma.com

ISO CERTIFICATIONS
Rasco iso-certified
rasco-logo-footer

Rasco Pharma started its operations in 2004. It is situated in the historical city of Lahore known as the heart of Pakistan. …

Contact us

Monday to Friday
@ 08:00 am to 5:00 pm
Tel: +92 42 35230774/5
Fax : +92 42 35230776
Email: info@rascopharma.com

Copyright © 2022 Rasco Pharma All Rights Reserved.
Designed & Developed by Wegaweb

Add to cart